Earnings whisper numbers circulating in market forums hint at a possible upside surprise for MYGN stock price, reinforcing trader confidence ahead of formal results release. Myriad Genetics’ shares have moved south slightly by 0.5% to $6.79 on Wednesday. Some other top-ranked stocks from the broader medical space are AngioDynamics ANGO , Integer Holdings Corporation ITGR and Boston Scientific BSX . Technical traders are watching MYGN stock price closely for a breakout above $17.50, which could be followed by a quick move to $18.20 based on historical price action.